SIRT6 and cancer: Finally, levels of SIRT6 were reportedly correlated with cancer progression and/or survival in colorectal cancer: Patients with low levels of nuclear SIRT6 had a shorter time to relapse and were more likely to relapse than those with high levels of nuclear SIRT6 (22).